James A. Graf - 06 Dec 2024 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)

Reporting relationship: Chief Financial Officer
Issuer ticker: NKGN
Reported as of: 06 Dec 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Dec 2024, 21:55:54 UTC
Prior SEC filing: 05 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ James Graf

Key filing fact

James A. Graf filed Form 4 for NKGen Biotech, Inc. (NKGN) on 10 Dec 2024.

Key facts

This page summarizes James A. Graf's Form 4 filing for NKGen Biotech, Inc. (NKGN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Dec 2024, 21:55.

Change

Previous filing in this sequence was filed on 05 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NKGN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +500,000
Change %
Price: $0.000000
Shares after: 500,000
Date: 06 Dec 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $0.4380
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On December 6, 2024, the Reporting Person was granted 500,000 options pursuant to the Company's 2023 Equity Incentive Plan, with 25% vesting immediately as of the grant date, and the remaining options vesting in 36 equal installments on the sixth of each month, beginning January 6, 2025, and ending December 6, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.